SCHEMBL790034

SCHEMBL790034

CCOC(=O)c1csc(Nc2ccccc2F)n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.60
RAB9A P51151 6/20 0.60
NPC1 O15118 5/20 0.60
MAPT P10636 3/20 0.57
KDM4E B2RXH2 3/20 0.57
TDP1 Q9NUW8 2/20 0.57
LMNA P02545 2/20 0.57
NPSR1 Q6W5P4 1/20 0.57
CYP1A2 P05177 1/20 0.56
CYP2C19 P33261 1/20 0.56
ALDH1A1 P00352 2/20 0.55
GAA P10253 2/20 0.55
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
HSP90AA1 P07900 2/20 0.52
MAPK1 P28482 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.50
ATM Q13315 1/20 0.49
EGFR P00533 1/20 0.49
MAOA P21397 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10464759 0.88 RAB9A (0.62) SMN1; SMN2RAB9ANPC1MAPTKDM4E
SCHEMBL21708013 0.86 MAPT (0.67) SMN1; SMN2RAB9ANPC1MAPTKDM4E
SCHEMBL21708015 0.86 MAPT (0.67) SMN1; SMN2RAB9ANPC1MAPTKDM4E
SCHEMBL789722 0.85 MAPT (0.73) SMN1; SMN2RAB9ANPC1MAPTKDM4E
SCHEMBL4789312 0.82 SMN1; SMN2 (0.69) SMN1; SMN2RAB9ANPC1MAPTKDM4E
SCHEMBL798484 0.82 NPC1 (0.55) SMN1; SMN2RAB9ANPC1MAPTKDM4E
SCHEMBL3602966 0.81 RAB9A (0.71) SMN1; SMN2RAB9ANPC1MAPTKDM4E
SCHEMBL23742650 0.80 MAPT (0.53) SMN1; SMN2RAB9ANPC1MAPTTDP1
SCHEMBL10464406 0.80 MAPT (0.65) SMN1; SMN2RAB9ANPC1MAPTKDM4E
SCHEMBL31507493 0.79 RAB9A (0.54) SMN1; SMN2RAB9ANPC1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012037349-A2 COMPOUNDS GLAXOSMITHKLINE LLC (US) 2012-03-22 WO disclosed
WO-2012037351-A1 COMPOUNDS GLAXOSMITHKLINE LLC (US) 2012-03-22 WO disclosed